Dexcel Pharma Technologies Ltd. - 10%+ Owner at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
PLX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dexcel Pharma Technologies Ltd. since 11/5/2023

Holdings reported by Dexcel Pharma Technologies Ltd. for Protalix BioTherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.64M $5.13M $1.41 Jun 3, 2021 Direct

Transactions reported by Dexcel Pharma Technologies Ltd. for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.